BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34967557)

  • 1. Uncovering Philip Morris International's Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame.
    Charoenca N; Kungskulniti N; Hamann S; Mock J
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3789-3801. PubMed ID: 34967557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand.
    Patanavanich R; Glantz SA
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33500264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retailer participation in cigarette company incentive programs is related to increased levels of cigarette advertising and cheaper cigarette prices in stores.
    Feighery EC; Ribisl KM; Schleicher NC; Clark PI
    Prev Med; 2004 Jun; 38(6):876-84. PubMed ID: 15193911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded 'Project Star' report.
    Gilmore AB; Rowell A; Gallus S; Lugo A; Joossens L; Sims M
    Tob Control; 2014 May; 23(e1):e51-61. PubMed ID: 24335339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How tobacco companies ensure prime placement of their advertising and products in stores: interviews with retailers about tobacco company incentive programmes.
    Feighery EC; Ribisl KM; Clark PI; Haladjian HH
    Tob Control; 2003 Jun; 12(2):184-8. PubMed ID: 12773729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco company agreements with tobacco retailers for price discounts and prime placement of products and advertising: a scoping review.
    Reimold AE; Lee JGL; Ribisl KM
    Tob Control; 2023 Sep; 32(5):635-644. PubMed ID: 35074932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philip Morris International's Formula 1 Sponsorship-Linked Marketing: Transformation From Marlboro to Mission Winnow.
    Dewhirst T; Lee WB; Czaplicki L
    Nicotine Tob Res; 2023 Nov; 25(12):1838-1846. PubMed ID: 37702346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International.
    Levy DT; Warner KE; Liber AC; Travis N; Sweanor DT; Meza R; Cummings KM
    Nicotine Tob Res; 2023 Nov; 25(12):1899-1903. PubMed ID: 37535864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful countering of tobacco industry efforts to overturn Thailand's ENDS ban.
    Patanavanich R; Glantz S
    Tob Control; 2021 Nov; 30(e1):e10-e19. PubMed ID: 33229463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'The last line of marketing': Covert tobacco marketing tactics as revealed by former tobacco industry employees.
    Watts C; Burton S; Freeman B
    Glob Public Health; 2021 Jul; 16(7):1000-1013. PubMed ID: 32946326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IQOS: examination of Philip Morris International's claim of reduced exposure.
    St Helen G; Jacob Iii P; Nardone N; Benowitz NL
    Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS.
    Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H
    Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Response of Retailers in Scotland to the Standardised Packaging of Tobacco Products Regulations and Tobacco Products Directive.
    Purves RI; Moodie C; Eadie D; Stead M
    Nicotine Tob Res; 2019 Feb; 21(3):309-313. PubMed ID: 30202853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Preparing ourselves to become an international organization': Thailand Tobacco Monopoly's regional and global strategies.
    MacKenzie R; Ross H; Lee K
    Glob Public Health; 2017 Mar; 12(3):351-366. PubMed ID: 28139965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries.
    Charoenca N; Mock J; Kungskulniti N; Preechawong S; Kojetin N; Hamann SL
    Int J Environ Res Public Health; 2012 Apr; 9(4):1111-34. PubMed ID: 22690186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation.
    Lee S; Lee K; Holden C
    Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
    Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
    Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From glass boxes to social media engagement: an audit of tobacco retail marketing in Indonesia.
    Astuti PAS; Kurniasari NMD; Mulyawan KH; Sebayang SK; Freeman B
    Tob Control; 2019 Dec; 28(e2):e133-e140. PubMed ID: 31147480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.